Increased serum osteopontin levels in autistic children: Relation to the disease severity

Brain, Behavior, and Immunity

Volumn 25, Issue 7, 2011, Pages 1393-1398

  AL ayadhi, Laila Y ^a   Mostafa, Gehan A ^a,b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Autism; Autoimmunity; Osteopontin; T helper 17

Indexed keywords

INTERLEUKIN 17; OSTEOPONTIN;

ARTICLE; AUTISM; AUTOIMMUNITY; CHILD; CHILDHOOD AUTISM RATING SCALE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RATING SCALE; TH17 CELL;

AUTISTIC DISORDER; AUTOIMMUNITY; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; OSTEOPONTIN; SEVERITY OF ILLNESS INDEX;

EID: 79960623614     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.04.006     Document Type: Article

References (64)

1. Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, American Psychiatric Association, Washington DC. 4th ed.
2. Angelidou, A., Alysandratos, K.D., Asadi, S., Zhang, B., Francis, K., Vasiadi, M., et al., 2011. Brief Report: " Allergic Symptoms" in Children with Autism Spectrum Disorders. More than Meets the Eye? J Autism Dev Disord. Jan 6 [Epub ahead of print].
3. Ashkar S., Weber G.F., Panoutsakopoulou V., Sanchirico M.E., Jansson M., Zawaideh S., et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000, 287:860-864.
4. Aspord C., Rome S., Thivolet C. Early events in islets and pancreatic lymph nodes in autoimmune diabetes. Journal of Autoimmunity 2004, 23:27-35.
5. Atladóttir H.O., Pedersen M.G., Thorsen P., Mortensen P.B., Deleuran B., Eaton W.W., et al. Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics 2009, 124(2):687-694.
6. Bettelli E., Oukka M., Kuchroo V.K. T(H)-17 cells in the circle of immunity and autoimmunity. Nature immunology 2007, 8:345-350.
7. Braitch M., Constantinescu C.S. The role of osteopontin in experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS). Inflamm. Allergy Drug Targets 2010, 9(4):249-256.
8. Cantor H., Shinohara M.L. Regulation of T-helper-cell lineage development by osteopontin the inside story. Nat. Rev. Immunol. 2009, 9(2):137-141.
9. Chabas D., Baranzini S.E., Mitchell D., Bernard C.C., Rittling S.R., Denhardt D.T., et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 2001, 294:1731-1735.
10. Chen M., Chen G., Nie H., Zhang X., Niu X., Zang Y.C., et al. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS. Eur. J. Immunol. 2009, 39(9):2525-2536.
11. Cohly H.H., Panja A. Immunological findings in autism. Int. Rev. Neurobiol. 2005, 71:317-341.
12. Comabella M., Pericot I., Goertsches R., Nos C., Castillo M., Blas Navarro J., et al. Plasma osteopontin levels in multiple sclerosis. J. Neuroimmunol. 2005, 158:231-239.
13. Comi A.M., Zimmerman A.W., Frye V.H., Law P.A., Peeden J.N. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J. Child Neurol. 1999, 14:388-394.
14. Croen L.A., Grether J.K., Yoshida C.K., Odouli R., Van de Water J. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch. Pediatr. Adolesc. Med. 2005, 159(2):151-157.
15. D'Alfonso S., Braizzone N., Giordano M., Chiocchetti A., Magnani C., Castelli L., et al. Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum. 2005, 52:539-547.
16. Denhardt D.T., Noda M., O'Regan A.W., Pavlin D., Berman J.S. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling and cell survival. J. Clin. Invest. 2001, 107(9):1055-1061.
17. Fan K., Dai J., Wang H., Wei H., Cao Z., Hou S., et al. Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells. Arthritis Rheum. 2008, 58(7):2041-2052.
18. Forton A.C., Petri M.A., Goldman D., Sullivan K.E. An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus. Hum. Mutat. 2002, 19:459.
19. Giachelli C.M., Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol. 2000, 19(7):615-622.
20. Gravallese E.M. Osteopontin: a bridge between bone and the immune system. J. Clin. Invest. 2003, 112:147-149.
21. Hur E.M., Youssef S., Haws M.E., Zhang S.Y., Sobel R.A., Steinman L. Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nature Immunol. 2007, 8:74-83.
22. Jansson M., Panoutsakopoulou V., Baker J., Klein L., Cantor H. Cutting edge: attenuated experimental autoimmune encephalomyelitis in eta-1/osteopontin-deficient mice. J. Immunol. 2002, 168:2096-2099.
23. Juszczak M., Glabinski A. Th17 cells in the pathogenesis of multiple sclerosis. Postepy. Hig. Med. Dosw. 2009, 63:492-501.
24. Kariuki S.N., Moore J.G., Kirou K.A., Crow M.K., Utset T.O., Niewold T.B. Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus. Genes Immun. 2009, 10(5):487-494.
25. Keil A., Daniels J.L., Forssen U., Hultman C., Cnattingius S., Söderberg K.C., et al. Parental autoimmune diseases associated with autism spectrum disorders in offspring. Epidemiology 2010, 21(6):805-808.
26. Koh A., da Silva A.P., Bansal A.K., Bansal M., Sun C., Lee H., et al. Role of osteopontin in neutrophil function. Immunology 2007, 122(4):466-475.
27. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177:566-573.
28. Lund S.A., Giachelli C.M., Scatena M. The role of osteopontin in inflammatory processes. J. Cell Commun. Signal. 2009, 3(3-4):311-322.
29. Mostafa G.A., Kitchener N. Serum anti-nuclear antibodies as a marker of autoimmunity in Egyptian autistic children. Pediatr. Neurol. 2009, 40:107-112.
30. Mostafa G.A., Shehab A. The link of C4B null allele to autism and to a family history of autoimmunity in Egyptian autistic children. J. Neuroimmunol. 2010, 223:115-119.
31. Mostafa G.A., El-Sayed Z.A., Abd El Aziz M.M., El-Sayed M.F. Serum anti-myelin-associated glycoprotein antibodies in Egyptian autistic children. J. Child Neurol. 2008, 23:1413-1418.
32. Mostafa G.A., El-Hadidi E.S., Hewedi D.H., Abdou M.M. Oxidative stress in Egyptian children with autism: relation to autoimmunity. J. Neuroimmunol. 2010, 219:114-118.
33. Mostafa G.A., Shehab A.Al., Fouad N.R. Frequency of CD4+CD25high regulatoryT cells in the peripheral blood of Egyptian children with autism. J. Child Neurol. 2010, 25:328-335.
34. Murugaiyan G., Mittal A., Weiner H.L. Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis. J. Immunol. 2008, 181(11):7480-7488.
35. Nagasaka A., Matsue H., Matsushima H., Aoki R., Nakamura Y., Kambe N., et al. Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells. Eur. J. Immunol. 2008, 38(2):489-499.
36. Odell D., Maciulis A., Cutler A., Warren L., McMahon W.M., Coon H., et al. Confirmation of the association of the C4B null allele in autism. Hum. Immunol. 2005, 66:140-145.
37. Onore C., Enstrom A., Krakowiak P., Hertz-Picciotto I., Hansen R., Van de Water J., et al. Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders. J. Neuroimmunol. 2009, 216(1-2):126-129.
38. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nature Immunol. 2005, 6:1133-1141.
39. Rothstein T.L., Guo B. Receptor crosstalk: reprogramming B cell receptor signalling to an alternate pathway results in expression and secretion of the autoimmunity-associated cytokine, osteopontin. J. Intern. Med. 2009, 265(6):632-643.
40. Samitas K., Zervas E., Vittorakis S., Semitekolou M., Alissafi T., Bossios A., et al. Osteopontin expression and relation to disease severity in human asthma. Eur. Respir. J. 2011, 37(2):331-341.
41. Sato T., Nakai T., Tamura N., Okamoto S., Matsuoka K., Sakuraba A., et al. Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response. Gut 2005, 54:1254-1262.
42. Schopler E., Reichler R.J., Renner B.R. The Childhood Autism Rating Scale (CARS) for Diagnostic Screening and Classification in Autism 1986, Irvington, New York, NY.
43. Shin T., Ahn M., Kim H., Kim H.M., Matsumoto Y. Increased expression of osteopontin in the heart tissue of Lewis rats with experimental autoimmune myocarditis. J. Vet. Med. Sci./Jpn. Society Vet. Sci. 2006, 68:379-382.
44. Shinohara M.L., Lu L., Bu J., Werneck M.B., Kobayashi K.S., Glimcher L.H., et al. Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat. Immunol. 2006, 7(5):498-506.
45. Shinohara M.L., Kim J.H., Kim J.H., Garcia V.A., Cantor H., et al. Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells. Proc. Natl. Acad. Sci. USA 2008, 105(20):7235-7239.
46. Shinohara M.L., Kim J.H., Garcia V.A., Cantor H. Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. Immunity 2008, 29(1):68-78.
47. Singh V.K. Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J. Neuroimmunol. 1996, 66(1-2):143-145.
48. Singh V.K., Rivas W.H. Prevalence of serum antibodies to caudate nucleus in autistic children. Neurosci. Lett. 2004, 355(1-2):53-56.
49. Singh V.K., Warren R.P., Odell J.D., Warren W.L., Cole P. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav. Immun. 1993, 7(1):97-103.
50. Singh V.K., Warren R., Averett R., Ghaziuddin M. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr. Neurol. 1997, 17(1):88-90.
51. Singh V.K., Lin S.X., Yang V.C. Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clin. Immunol. Immunopathol. 1998, 89(1):105-108.
52. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat. Med. 2007, 13(2):139-145.
53. Stromnes I.M., Goverman J.M. Osteopontin-induced survival of T cells. Nature Immunol. 2007, 8:19-20.
54. Stromnes I.M., Cerretti L.M., Liggitt D., Harris R.A., Goverman J.M. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nature Med. 2008, 14:337-342.
55. Sweeten T.L., Bowyer S.L., Posey D.J., Halberstadt G.M., McDougle C.J. Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics 2003, 112(5):420-424.
56. Theoharides T.C. Autism spectrum disorders and mastocytosis. Int. J. Immunopathol. Pharmacol. 2009, 22(4):859-865.
57. Theoharides, T.C., Angelidou, A., Alysandratos, K.D., Zhang, B., Asadi, S., Francis, K., et al., 2010. Mast cell activation and autism. Biochim Biophys Acta. December 28 [Epub ahead of print].
58. Vaknin-Dembinsky A., Balashov K., Weiner H.L. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J. Immunol. 2006, 176:7768-7774.
59. Vogt M.H., Floris S., Killestein J., Knol D.L., Smits M., Barkhof F., et al. Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients. J. Neuroimmunol. 2004, 155(1-2):155-160.
60. Vojdani A., Campbell A.W., Anyanwu E., Kashanian A., Bock K., Vojdani E. Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. J. Neuroimmunol. 2002, 129(1-2):168-177.
61. Warren R.P., Singh V.K., Cole P., Odell J.D., Pingree C.B., Warren W.L., White E. Increased frequency of the null allele at the complement C4b locus in autism. Clin. Exp. Immunol. 1991, 83:438-440.
62. Wesson J.A., Johnson R.J., Mazzali M., Beshensky A.M., Stietz S., Giachelli C., et al. Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J. Am. Soc. Nephrol. 2003, 14(1):139-147.
63. Wong C.K., Lit L.C., Tam L.S., Li E.K., Lam C.W. Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus. Rheumatology (Oxford, England) 2005, 44:602-606.
64. Zhao, B., Sun, T., Meng, F., Qu, A., Li, C., Shen, H., et al., 2011. Osteopontin as a potential biomarker of proliferation and invasiveness for lung cancer. J Cancer Res Clin Oncol. Jan 5. [Epub ahead of print].